Story thread · 6 reports / 6 sources
Biohaven Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Biohaven (BHVN)
buffalonews.com · 3d
How the coverage leans
Across 6 sources · syndicated copies counted once
Biohaven shares gave up nearly 15% in a single session on September 10, 2026 following the FDA's partial clinical hold on new-patient enrollment in the BHV-7000/opakalim epilepsy trials
First report: FDA Places Partial Hold on BHV-7000 Trials — ijr.com, 5d
The coverage
- FDA places partial hold on Biohaven’s epilepsy drug
biopharmadive.com · 4d
- FDA places partial hold on Biohaven's ion channel drug
endpts.com · 4d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.